Gossamer Bio
GOSS
#9712
Rank
ยฃ70.31 M
Marketcap
ยฃ0.14
Share price
40.81%
Change (1 day)
-90.24%
Change (1 year)

Revenue for Gossamer Bio (GOSS)

Revenue in 2026 (TTM): ยฃ41.3 Million

According to Gossamer Bio's latest financial reports the company's current revenue (TTM ) is ยฃ41.71 Million. In 2025 the company made a revenue of ยฃ35.99 Million a decrease over the revenue in the year 2024 that were of ยฃ91.4 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Gossamer Bio from 2018 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ41.3 M14.76%
2025 ยฃ35.99 M-60.62%
2024 ยฃ91.4 M
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA